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Abstract
Mounting evidence suggests the interaction between stress and genetics contribute to the
development of depressive symptoms. Currently, the molecular mechanisms mediating
this process are poorly understood, hindering the development of new clinical interventions.
Here, we investigate the interaction between neuropsin, a serine protease, and chronic
stress on the development of depressive-like behaviours in mice. We found no difference in
baseline behaviour between neuropsin knockout and wild-type mice. However, our results
show that neuropsin knockout mice are protected against the development of depressive-
like behaviours and memory impairment following chronic stress. We hypothesised that
this difference in behaviour may be due to an interaction between neuropsin and elevated
plasma corticosterone. To test this, we subjected mice to chronic corticosterone injections.
These injections resulted in changes to hippocampal structure similar to that observed fol-
lowing chronic stress. We found that inactivation of neuropsin limits the extent of these
anatomical changes in both the chronic stress and the corticosterone injection exposed
cohorts. We next used viral vectors to knockdown or overexpress neuropsin in the hippo-
campus to confirm the results of the KO study. Additionally, we found that inactivation of
neuropsin limited glutamate dysregulation, associated with increased generation of reac-
tive oxygen species, resulting from prolonged elevated plasma corticosterone. In this
study, we demonstrate that neuropsin inactivation protects against the impairment of hippo-
campal functions and the depressive-like behaviour induced by chronic stress or high levels
of corticosterone. Consequently, we suggest neuropsin is a potential target for clinical inter-
ventions for the management of stress disorders.
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Author Summary
Depression is a medical condition that results in significantmorbidity, mortality and
reduced quality of life. Understanding the molecularmechanism in which stress leads to
depression is essential for the discovery of new clinical interventions. Currently, despite
considerable research, the mechanisms underlying stress-related illnesses are unclear. In
this study, we reveal a novel link between the interaction of serine protease neuropsin with
corticosterone and the development of chronic stress induced depressive-like behaviour.
We found no difference in baseline behaviour between neuropsin knockout and wild-type
mice. However, our results show that neuropsin knockout mice are protected against the
development of depressive-like behaviours and memory impairment following chronic
stress. We suggest the dysregulation of the glutamate systemmay lead to increased reactive
oxygen species and act as a possible mechanism in which stress changes hippocampal
architecture. We found that inactivation of neuropsin limits the extent of these anatomical
changes in both chronic stress and corticosterone injection exposed cohorts. In this study,
we outline a mechanism that may open new possibilities for the treatment of stress-related
psychiatric disorders.
Introduction
Stress, especially chronic stress, can lead to disorders such as depression and consequently
result in significantmorbidity and reduced quality of life [1]. Despite considerable research,
the mechanisms underlying stress-related illnesses are unclear. Neuropsin (NP, also named
Klk8) is a serine protease that exhibits trypsin-like activity with a strong preference for Arg in
the P1 position [2]. Its substrates include neuregulin-1, fibronectin, vitronectin, synaptic
adhesion molecule L1, and Ephrin type-B receptor 2 (EphB2) [3–6]. Neuropsin is predomi-
nantly expressed in the amygdala and CA regions of the hippocampus [6–8]. These two
regions have been long associated with stress, emotion, learning and memory processes [9–
11]. There are several pieces of evidence suggesting a link between neuropsin and stress. First,
stress increases the expression of neuropsin mRNA in the hippocampus through a glucocorti-
coid-sensitive pathway [12]. Second, neuropsin has been shown to affect stress-induced anxi-
ety by cleaving the extracellular portion of EphB2 [6]. Finally, the antidepressant fluoxetine
alters the expression of neuropsin in the hippocampus [13]. However, the importance of neu-
ropsin in chronic stress induced impairment of brain function and behaviour still remains
unknown.
In this study, we sought to investigate the role of neuropsin in the regulation of depressive-
like behaviour, learning and memory following chronic stress. It is well known that stress
induces a rapid rise in corticosterone. Chronically elevated corticosterone impairs memory,
reduces neuronal spine density, and decreases hippocampal neurogenesis and volume [14–17].
Therefore, we further explored the interaction between corticosterone and neuropsin and the
associated effects on behaviour, gene expression and hippocampal architecture. We investi-
gated the role of neuropsin using multiple models: a knock out; a lenti-viral vector induced
knock down; and an AAV vector induced overexpression model. Our results suggest that
understanding the role of neuropsin in the brain may open new possibilities for the treatment
of stress-associated disorders.
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Results
The severity of depressive-like behaviours induced by chronic stress is
reduced in neuropsin-deficient mice
To investigate whether neuropsin expression is influenced by stress, we examined the expres-
sion of neuropsin in the hippocampus following acute and chronic restraint exposure. Eight
week old C57BL/6 male mice were subjected to restraint stress for 30 min to model acute stress
(n = 4) or for 28 days to model chronic stress (n = 8). Mice were killed and hippocampal neu-
ropsin mRNA was quantified with real-time PCR. The data show hippocampal neuropsin
expression was increased after both acute restraint stress (mean ± SEM; control: 1.00 ± 0.09;
stress: 1.5 ± 0.17, p = 0.036, t = 2.68) and 28 days chronic stress (control: 1.00 ± 0.192; stress:
1.94 ± 0.24, p = 0.029, t = 2.53).
Next, we used neuropsin knockout (KO) mice (n = 8) and wild-type (WT) mice (n = 10) to
conduct tests to assess depressive-like behaviour; this included novelty suppressed feeding,
forced swim, and a sucrose preference test. Our data showed there was no difference between
WT and KO mice for depressive-like behaviour (Fig 1A, 1C and 1E). Whilst a previous study
suggested that neuropsin KO mice exhibit less anxiety compared to WT following acute
restraint stress [6], the role of neurospin in chronic stress remained unclear. To study this, both
KO (n = 9) andWT (n = 10) mice were subjected to a battery of restraint stress, footshock and
sleep deprivation for 28 days (one stress paradigm per day). Behavioural tests were started on
the 12th day of the 28 day stress protocol. We first measured the activity of mice using an open
field test. The result showed there was an effect from stress but there was no significant differ-
ence between theWT and KO groups (effect of stress, F1,34 = 10.33, p = 0.003; NP, p = 0.28)
(S1A Fig). In the novelty suppressed feeding test, KO mice approached food pellets quicker
thanWTmice (p = 0.001, t = 3.83). For the forced swim test, the immobility time of KO mice
was less thanWT (p = 0.031, t = 2.37). Additionally, neuropsin KO mice drankmore sucrose
in the sucrose preference test (p = 0.0054, t = 3.18) (Fig 1A, 1C and 1E). These results indicate
that neuropsin KO mice showed less depressive-like behaviour following chronic stress com-
pared to littermate WTmice.
Mice lacking neuropsin feature a reduction in the impairment of both
memory and hippocampal neurogenesis observed following chronic
stress
Memory is affected by numerous factors including stress and depression. Neuropsin has been
suggested to be essential for memory acquisition, although some inconsistencies exist in the lit-
erature [18–21]. To further investigate whether neuropsin is involved in learning and memory
following chronic stress, we used two independent cohorts of mice to perform a water maze
test. First, we measured the basal level of learning and memory. WT and KO mice (n = 11) had
four trials a day for three days. Assessments of spatial memory were obtained by placing mice
in the water maze without a platform two weeks after training and recording the time spent in
the target zone and the number of times they crossed the phantom platform location. Results
show there was no difference between the two training curves (escape latency) (Repeatedmea-
sures ANOVA, p = 0.69, F11,220 = 0.16). In the memory test, there were also no differences in
the time spent in the target zone (p = 0.33, t = 0.98) and the number of phantom platform
crosses (p = 0.68, t = 0.41) (Fig 2A and 2B). These data indicate that neuropsin inactivation
does not affect basal learning and memory as measured in a water maze. Next, we assessed spa-
tial learning and memory in another cohort of mice (n = 10) which had experienced chronic
stress (training started from day 12). Results showed no difference in the training curves
Neuropsin and Stress in Depressive-Like Behaviours
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(p = 0.81, F11,187 = 0.054). However, the memory test showed KO mice spent more time in the
target zone (p = 0.0018, t = 3.69) and made more phantom platform crosses (p = 0.0069,
t = 3.07) (Fig 2A and 2B). These results suggest that in mice exposed to chronic stress, a lack of
neuropsin does not influence spatial learning, but does improve indicators of memory.
Fig 1. Neuropsin-deficient mice are resistant to chronic stress or elevated corticosterone induced depressive-like behaviour. (A, C,
E) There is no significant difference between WT and KO mice in the novelty suppressed feeding, forced swim or sucrose preference tests
without prior exposure to stress. After chronic stress, neuropsin KO mice approach food pellets more quickly than WT mice in the novelty
suppressed feeding test. In the forced swim test, the immobility time of KO mice is shorter than WT mice. KO mice drink more sucrose than WT
mice in the sucrose preference test. (B, D, F) There is no significant difference between WT and KO mice in the oil injection group. After chronic
corticosterone injection (20 mg/kg/day), neuropsin KO mice show less depressive-like behaviour in novelty suppressed feeding, forced swim
test, and sucrose preference test than WT mice. n = 8–10 in each group, values represent mean ± SEM. * p < 0.05, ** p < 0.01.
doi:10.1371/journal.pgen.1006356.g001
Neuropsin and Stress in Depressive-Like Behaviours
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Fig 2. Inactivation of neuropsin reduces the impairment of spatial memory performance following chronic stress or elevated
corticosterone. (A) There is no significant difference in the water maze training curve between KO and WT mice. In the chronic stress
groups, there is also no difference in the training curve. (B) Two weeks later, there is no significant difference in memory as measured by time
spent in the target zone and the number of phantom platform crosses; however in the chronic stress group, neuropsin KO mice spent more
time in the target zone and made a greater number of phantom platform crosses. (C) In both oil and corticosterone injection groups (20 mg/kg/
day) there is no difference in the training curves. (D) KO mice performed significantly better in memory tests that WT following corticosterone
injection. n = 10–11 in each group, values represent mean ± SEM. * p < 0.05, ** p < 0.01.
doi:10.1371/journal.pgen.1006356.g002
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Neurogenesis has the effect of buffering stress and depressive-like behaviours and has long
been associated with learning and memory [22, 23]. Previous research has demonstrated the
status of the CA3 region can affect the survival of newly born neurons in the dentate gyrus
[24]. Here, we asked whether neuropsin plays a role in the regulation of adult hippocampal
neurogenesis following chronic stress. Mice were divided into four groups (WT, KO, n = 7;
WT, KO with chronic stress, n = 10 in each group). The day prior to the commencement of
the chronic stress protocol, mice were injected with 5-bromo-2'-deoxyuridine (BrdU) (200
mg/kg, i.p.) to label newly born cells. Mice were killed 28 days after BrdU injection to evaluate
cell survival of new neurons generated at the time of BrdU injection. To assess proliferation of
neuronal progenitors at the time of culling, we stained for doublecortin (DCX), a marker for
immature neurons, and KI67, a marker for cell proliferation.
A two-way ANOVA revealed a significant stress effect on neurogenesis (DCX: F1,29 = 30.7,
p< 0.0001; BrdU: F1,29 = 389.7, p< 0.0001, KI67: F1,29 = 7.6, p = 0.01). For the DCX, BrdU,
and KI67 cell counts in the dentate gyrus, there were no significant differences betweenKO
andWTmice (p> 0.05). In the chronic stress groups, we detectedmore DCX (p = 0.002,
t = 3.3) and BrdU (p< 0.0001, t = 4.71) positive cells in the dentate gyrus of KO mice com-
pared toWTmice. However, there was no significant difference in KI67 cell count (p = 0.86,
t = 0.17) (Fig 3A–3C). Overall, these results suggest neuropsin does not affect neurogenesis
under normal conditions but does play a role, especially in cell survival, when mice experience
chronic stress.
Neuropsin interacts with corticosterone to influence behaviour and
hippocampal architecture
Corticosterone is released in response to stress. To confirmwhether the stress models we used
increased plasma corticosterone, we measured basal levels in both neuropsinWT and KO
mice (n = 8) and levels after 3 hrs of restraint stress, 30 min after footshock, after 6 hrs of
sleep deprivation and 24 hrs after all stressors were completed. Our result showed that the
stressors we used in this study elevated plasma corticosterone (Two way ANOVA; F4,56 =
91.24, p< 0.0001) and there was no significant difference betweenWT and KO mice (basal,
p = 0.69, t = 0.4; restraint, p = 0.15, t = 1.5; footshock, p = 0.77, t = 0.29; sleep deprivation,
p = 0.16, t = 0.48; 24 hrs after stress, p = 0.34, t = 0.98) (S2 Fig).
In our experiment, we sought to establish whether our findings on behaviour after chronic
stress were due to an interaction between elevated corticosterone and neuropsin inactivation.
To do so, KO andWTmice were injectedwith oil (KO/oil, n = 12 andWT/oil, n = 10) or corti-
costerone (KO/CORT, n = 8 andWT/CORT, n = 10, 20 mg/kg/day, subcutaneously) daily for
32 days to imitate the elevated corticosterone during chronic stress. On day 12, we conducted a
battery of tests for assessing depressive-like behaviour, learning and memory.
No differences were found in any of the behavioural tests from the oil injected groups. (Figs
1B, 1D, 1F and 2C and 2D). However, in the corticosterone injected groups, we found that KO
mice exhibited less depressive-like behaviour thanWTmice. Corticosterone significantly
decreased activity but there was no significant difference betweenWT and KO groups (effect of
corticosterone, F1,37 = 0.3, p< 0.0001; effect of neuropsin P = 0.58) (S1B Fig). KO mice had a
reduced latency to approach food pellets in the novelty suppressed feeding test (p = 0.002,
t = 3.54), reduced immobility time in the forced swim test (p = 0.039, t = 2.22) and drankmore
sucrose thanWTmice in the sucrose preference test (p = 0.04, t = 2.18) (Fig 1B, 1D and 1F).
On day 17, mice were trained in the water maze, and memory performance was assessed two
weeks later. There was no difference in the training curves betweenWT and KO (p = 0.54,
F11,176 = 0.39). However, for the memory test, the KO mice spent more time in the target zone
Neuropsin and Stress in Depressive-Like Behaviours
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(p = 0.026, t = 2.44) and made more phantom platform crosses (p = 0.006, t = 3.11) (Fig 2C and
2D). These results suggest that corticosterone interacts with neuropsin to affect spatial memory
performance.
Evidence shows that hippocampal neurogenesis is inhibited by corticosterone [25]. Conse-
quently, we sought to ascertainwhether neuropsin interacts with corticosterone to regulate
neurogenesis. Our data shows that corticosterone injection strongly reduced hippocampal neu-
rogenesis (DCX: F1,20 = 131.6, p< 0.0001; BrdU: F1,20 = 71.96, p< 0.0001; KI67: F1,20 = 75.64,
p< 0.0001). However, there was a significantly higher level of DCX (p = 0.043, t = 2.15) and
BrdU (p = 0.003, t = 3.38) cell counts, but not KI67 (p = 0.19, t = 1.34) in the dentate gyrus in
the neuropsin KO compared to WT (Fig 3A–3C). This suggests neuropsin interacts with
plasma corticosterone to influence cell survival but not proliferation in the dentate gyrus.
In regards to dendriticmorphology, it is known that elevated corticosterone reduces hippo-
campal dendritic spine density [26], which has been suggested to be important for learning and
Fig 3. Neuropsin-deficient mice are partially protected against the effect on hippocampal neurogenesis elicited by chronic stress or
corticosterone injection. (A) Chronic stress (n = 7–10) or chronic corticosterone injections (n = 6) dramatically decrease hippocampal neurogenesis.
Neuropsin KO mice have a higher cell count of DCX positive cells in the dentate gyrus. (B) There are more BrdU positive cells in the dentate gyrus in KO
mice than WT mice. (C) There is no significant difference in KI67 cell counts in both groups; n = 7–10 for chronic stress groups, n = 6 for chronic
corticosterone groups. Scale bar = 200μm, values represent mean ± SEM. * p < 0.05, ** p < 0.01.
doi:10.1371/journal.pgen.1006356.g003
Neuropsin and Stress in Depressive-Like Behaviours
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memory [27]. To better understand whether neuropsin interacts with corticosterone to affect
dendritic structure, we utilisedGolgi staining to analyse the spine density in CA3. Our data
showed corticosterone reduced spine density significantly (F1,12 = 127.3, p< 0.0001). There
was no significant difference in spine density betweenWT and KO mice with oil injection
(p = 0.42, t = 0.82). In the corticosterone injected groups, KO mice exhibited a higher spine
density thanWTmice (p = 0.0002, t = 5.22) (Fig 4A and 4B).
Stress may accelerate the ageing process and accelerate neurodegeneration [28]. Previous
studies have shown that neuropsin is expressed in oligodendrocytes after injury to the central
nervous system [29] and that prolonged corticosterone treatment of adult rats inhibits the pro-
liferation of oligodendrocyteprogenitors [30]. To better understand the role of neuropsin in
the regulation of demyelination, we quantifiedCnp (2',3'-Cyclic-nucleotide 3'-phosphodiester-
ase) andMog (Myelin OligodendrocyteGlycoprotein) expression from hippocampus and
cortex derivedmRNA after chronic oil or corticosterone injection (n = 6). There was no signifi-
cant difference betweenWT and KO in both the hippocampus and cortex in the oil injected
groups. However, in the corticosterone injected groups, whilst there was no difference in the
Fig 4. Neuropsin interacts with corticosterone to influence dendritic spine density and myelination. (A, B) The
hippocampal dendritic spine density decreases in both WT and KO mice following chronic corticosterone injections but
KO mice preserve more dendritic spines compared to WT mice, n = 4, Scale bar = 10μm. (C, D) Immunohistochemistry
staining of CNPase in cortex and hippocampus. Scale bar = 200μm. (E, F) After chronic corticosterone injections, KO
mice retain a higher expression of Cnp and Mog compared to WT mice in the hippocampus but there is no significant
difference in the cortex. n = 6 in each group, values represent mean ± SEM. * p < 0.05, ** p < 0.01.
doi:10.1371/journal.pgen.1006356.g004
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cortex, there was more expression of Cnp (p = 0.04, t = 2.23) andMog (p = 0.03, t = 2.4) in the
hippocampus of KO mice (Fig 4C–4F).
Collectively, these data demonstrate that mice lacking neuropsin feature a protective effect
on neurogenesis, dendriticmorphology, and demyelination in the hippocampus after chronic
elevated plasma corticosterone.
Neuropsin inactivation decreases hippocampal neuronal activity
following corticosterone injection
The expression of c-Fos is commonly used as a neuronal activity marker following stimulus
[31]. In order to better understand the neuronal activity in WT and KO hippocampi in
response to high levels of corticosterone, we measured neuronal activation by detecting the
number of c-Fos positive cells twenty-four hours after the last injection of corticosterone or
oil (28 days of injections) in bothWT and KO mice (n = 6 in each group). In the oil treated
groups, our results show there was no difference betweenWT and KO mice. Interestingly,
after corticosterone injection,WTmice had more c-Fos positive cells in the dentate gyrus
(DG) (p = 0.02, t = 2.7) and CA3 (p = 0.001, t = 4.3), but not in the CA1 (p = 0.31. t = 1.06).
Meanwhile, KO/CORT mice featured significantly fewer c-Fos positive cells in CA1 (p = 0.03,
t = 2.43) and CA3 (p< 0.0001, t = 8.87), but no significant difference in DG (p = 0.33,
t = 1.01) compared to WT/CORTmice (Fig 5). These results demonstrate that KO mice
exhibit a reduced response to corticosterone treatment as measured by hippocampal c-Fos
expression.
AAV mediated overexpression of neuropsin leads to depressive-like
behaviour and memory impairment following corticosterone injection
One of the major limitations of using constitutive KO animals is that aberrant development
may potentially influence data. The KO model may have an effect on somatic cells and brain
regions other than the hippocampus. To address this, we overexpressed neuropsin in the hip-
pocampi of KO mice via an AAV9-CB-neuropsin viral vector (NP/OE, n = 8) together with an
AAV9-CB-GFP control (NP/KO, n = 8). Two weeks after surgery, we started to inject mice
with corticosterone (20 mg/kg/day). After 14 days of corticosterone injections, we subjected
the mice to a forced swim test, novelty suppressed feeding test and a sucrose preference test.
Interestingly, NP/OEmice have longer immobility times in the forced swim test (p = 0.003,
t = 3.62), and a greater latency to approach food pellets in the novelty suppressed feeding test
(p = 0.018, t = 2.72) in comparison with NP/KO mice. For the sucrose preference test, there
was no significant difference between the two groups (p = 0.09, t = 1.84) (S3A Fig). Our data
shows that overexpression of neuropsin with concordant corticosterone injections leads to
depressive-like behaviour.
Next, we performed a water maze test to measure spatial learning and memory. There was
no significant difference between the learning curves of both groups (p = 0.99, F11,66 = 0.0004).
We performed a memory test two weeks after training. The results showed no significant dif-
ference spent in the target zone between groups (p = 0.172, t = 1.45) but the number of times
NP/OEmice crossed the phantom platform was significantly fewer (p = 0.03, t = 2.33). This
suggests overexpression of neuropsin may further impair spatial memory after chronic cortico-
sterone injection (S3B Fig). We confirmedhippocampal neuropsin overexpression by using
qPCR. NP/OEmice featured a dramatic increase in neuropsin mRNA compared with NP/KO
mice and NP/WTmice (one- way ANOVA, p = 0.0006, F2,12 = 14.96) (S4B Fig).
Neuropsin and Stress in Depressive-Like Behaviours
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Lentiviral vector knockdown of neuropsin attenuates depressive-like
behaviour and memory impairment after corticosterone injection
In contrast to the overexpression group, we performed surgery on wild type C57BL/6 mice
(n = 9) and injected either scramble sequence control or lentiviral vector shRNA to knockdown
neuropsin in the hippocampus. Two weeks after surgery, we injected corticosterone daily on all
mice. After 14 days of corticosterone injection, we evaluated the mice using the behaviour tests
described above. Mice injected with the control scrambled viral vector featured a longer immo-
bility time in the forced swim test (p< 0.0001, t = 6.34) and took a longer time to approach a
food pellet in the novelty suppressed feeding test (p = 0.01, t = 2.74). There was no significant
difference between control and knockdown in the sucrose preference test (p = 0.06, t = 2.04)
Fig 5. Inactivation of neuropsin blocks corticosterone induced hippocampal neuronal activity. (A) One day after chronic corticosterone or oil
injection in WT and KO mice, c-Fos positive cells in the dentate gyrus (DG), CA1 and CA3. (B-D) Quantification of c-Fos positive cells in the DG, CA1,
and CA3. KO/CORT mice display fewer c-Fos positive cells in the CA1 and CA3 compared to WT/CORT mice. n = 6 in each group, scale bar = 200 μm,
values represent mean ± SEM. * p < 0.05, *** p < 0.001.
doi:10.1371/journal.pgen.1006356.g005
Neuropsin and Stress in Depressive-Like Behaviours
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(S3C Fig). Overall, these data suggest that inactivation of neuropsin protects against depres-
sive-like behaviour.
Next, we performed a water maze test to evaluate spacial learning and memory. The results
showed no significant difference in the learning curves between groups (p = 0.06, F11,88 = 4.49).
Again, we performed the memory test two weeks after training. The results were consistent
with the overexpression group: knockdownmice made significantlymore platform crosses
than the control group (p = 0.02, t = 2.39) but there was no significant difference in time spent
within the target zone (p = 0.18, t = 1.38) (S3D Fig). The expression analysis showed shRNA
lentiviral vector significantly decrease neuropsin expression compared to the scramble control
(p< 0.0001, t = 7.73) (S4C Fig).
Inactivated neuropsin prevents glutamate dysregulation and lowers
reactive oxygen species production elicited by corticosterone
To further investigate the mechanism of how neuropsin interacts with corticosterone to affect
animal behaviour and hippocampal architecture, we analysed hippocampal gene and protein
expression in four groups (n = 6 in each group): WT/oil, KO/oil, WT/CORT, and KO/CORT.
We first measured the hippocampal gene expression of neuropsin (Klk8). As expected,Klk8
expression was not detectable in KO mice. However, Klk8 expression was increased after
chronic corticosterone injection inWTmice (p = 0.03, t = 2.46). For GR (glucocorticoid recep-
tor), KO/CORT mice had higher expression compared toWT/CORTmice (p = 0.04, t = 2.3).
This change can also be detected at the protein level (p = 0.03, t = 2.45) (Fig 6A and 6D). Next,
we analysed GR downstream target genes: serum and glucocorticoid-regulatedkinase 1 (Sgk1)
and FK506 binding protein 5 (Fkbp5). Sgk1 is thought to transfer N-methyl-D-aspartate
(NMDA) receptors to the plasma membrane and have a regulating function in learning and
memory and also mediate the effect of glucocorticoidson neurogenesis and brain function
including learning and memory [32–34]. Fkbp5 is highly associated with depression and other
psychiatric disorders and is thought to reduce ligand sensitivity of the GR and be involved in
stress response [35, 36]. KO/CORT mice showed a lower level of Sgk1 expression compared to
WT/CORTmice (p = 0.0004, t = 5.25) and no difference in Fkbp5 (p = 0.25, t = 1.27) (Fig 6A,
6E and 6F). With regard to protein levels, western blot results show no differences in both
SGK1 and Fkbp5 protein expression. These results provide evidence that mice lacking neurop-
sin have a reduced response to elevated plasma corticosterone.
It has been suggested that the imbalance of glutamate transmission is pathogenic in mood dis-
orders [37]. Therefore, we measured the expression of regulatory genes that are involved in the
removal (reuptake) of glutamate from the neuronal synaptic cleft in the hippocampus.We show
that corticosterone injection reduces the expression of excitatory amino-acid transporter 1
(EAAT1) gene expression (F1,20 = 15.63, p = 0.0008). In corticosterone injectedmice, KO mice
have a higher level of EAAT1 gene expression (p = 0.008, t = 3.23) thanWT controls. This differ-
ence between genotypes is also observedat the protein level (p = 0.027, t = 2.59) (Fig 6B and 6I).
Expression of the vesicular glutamate transporter, VGluT1, is increased by corticosterone (F1,20 =
60.72, p< 0.0001). There was no difference in VGluT1 mRNA expression betweenKO/CORT
andWT/CORT (Fig 6B). These data suggest that chronic corticosterone treatment reduces the
efficiencyof glutamate reuptake and that neuropsin inactivation partially rescues this defect.
Emerging evidence suggests NMDA receptor dysregulation is implicated in stress induced
depressive-like behaviours [38]. To better understand the interaction of neuropsin and cortico-
sterone in regulating NMDA receptors, we measured different subtypes of NMDA receptors in
the hippocampus, including 2A (GluN2A) and 2B (GluN2B). KO/CORT mice had significantly
lower expression of GluN2B compared toWT/CORT (p = 0.006, t = 3.44) but no significant
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difference in GluN2A. The protein expression of NR2B showed a similar pattern to gene
expression but there was no significant difference betweenWT/CORT and KO/CORT. We
also detected a lower level of Camk2b gene (p = 0.014, t = 2.93) and CamKII protein (p = 0.036,
t = 2.41) expression in KO/CORT mice compared toWT/CORTmice but no difference in
Camk2a expression (Fig 6B, 6G and 6H). These results suggest that neuropsin inactivation
may prevent increased calcium influx seemingly induced by corticosterone injection.
Previous studies show that activation of NMDA receptors induces reactive oxygen species
(ROS) production in neurons [39]. Evidence also suggests high levels of plasma corticosterone
Fig 6. Neuropsin-deficient mice are resistant to glutamate transmission dysregulation induced by chronic elevated plasma corticosterone.
(A) Gene expressions of Klk8, GR, Sgk1 and Fkbp5 in the hippocampus in WT and KO mice after chronic corticosterone or oil injection. (B) Gene
expressions of glutamate receptors, GluN2A, GluN2B and Camk2b and glutamate reuptake (EAAT1), vesicle packing (VGluT1) in hippocampus. (C)
Detection of NADPH induced reactive oxygen species in the hippocampus of WT and KO mice after chronic corticosterone or oil injection. n = 9–13 in
each group. (D-I) Protein expressions of GR, SGK1, Fkbp5, NR2b, EAAT1 and CamKII measured by western blot assay. n = 6 in each group, values
represent mean ± SEM. * p < 0.05, ** p < 0.01.
doi:10.1371/journal.pgen.1006356.g006
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triggers ROS production leading to oxidative damage in the hippocampus and impairment of
memory retention [40]. To test this hypothesis, we conducted a NADPH oxidase-dependent
ROS test. In the oil treated groups, our results show no difference in superoxide anion produc-
tion betweenWT/oil (n = 13) and KO/oil (n = 15) mice. However, KO/CORT mice (n = 9)
have lower superoxide anion in the hippocampus compared to WT/CORT (n = 10) induced by
NADPH (p = 0.013, t = 2.75) (Fig 6C). This suggests that neuropsin inactivation reduces ROS
generation resulting from prolonged exposure to a high level of plasma corticosterone.
Discussion
In this study, we set out to investigate the role of neuropsin in depressive-like behaviour follow-
ing chronic stress. We observed significant differences in depressive-like behaviour between
neuropsin KO andWTmice. However these differences were only evident after animals had
experienced a chronic stress regime. Neuropsin is highly expressed in the hippocampus; a
region with high neuronal plasticity that has long been considered to be involved in stress,
depression, learning and memory. From previous studies, it is unclear whether neuropsin plays
a role in learning and memory. One report suggested that neuropsin knockout mice exhibit
impairment in the water maze test and that neuropsin is necessary for establishment of LTP,
thereby playing a significant role in memory acquisition [20]. However, another study shows
no difference in water maze behaviour betweenKO andWTmice [21]. In our study, intrigu-
ingly, we did not detect any difference in learning and memory betweenWT and KO mice
prior to chronic stress. However, after experiencing chronic stress, KO mice performed better
in memory tasks thanWTmice. Chronic stress leads to disorders such as depression through
prolonged elevated glucocorticoids and it is well known that depression may alter the function
of learning and memory [17]. From our previous study, we showed that a combination of dif-
ferent stressors leads to depressive-like behaviours in mice [41]. In this study, we used a combi-
nation of restraint, foot shock, and sleep deprivation stressors. We confirmed that this array of
stressors elicited an increase in plasma corticosterone.We also confirmed that there was no sig-
nificant difference in plasma corticosterone level betweenWT and KO groups at each stage of
the experiment: before, during and after stress. Our data show that inactivation of neuropsin
protects mice from developing depressive-like behaviours and limited the impairment of mem-
ory following stress, possibly due to the interaction between neuropsin and corticosterone.
Neuropsin has been shown to be involved in anxiety following acute stress by regulating the
dynamics of the EphB2-NMDA-receptor interaction [6]. This suggests there may be an inter-
action between neuropsin and corticosterone in emotional response. In order to investigate the
interaction between neuropsin and corticosterone on depressive-like behaviour and memory,
we mimicked one aspect of the hormonal state observedduring prolonged stress by injecting
mice with a high dose of corticosterone. After chronic corticosterone injection, we observed
similar effects to that observed in the chronically stressed animals. Our results suggest that the
effects of stress in neuropsin-deficientmice on emotional behaviours and memory perfor-
mance may be mediated by elevated plasma corticosterone. Additionally, it is also well known
that stress or elevated corticosterone can result in excitotoxicity and the modification of hippo-
campal architecture including decreased dendritic spine density, neurogenesis, and myelina-
tion [14, 15, 42, 43]. Our data suggest neuropsin deficient mice are protected against the effects
of prolonged elevated corticosterone. This is supported by an assessment of neuronal activity
as measured by c-Fos expression. Previous evidence demonstrated elevated plasma corticoste-
rone can be detectedmore than twelve hours after subcutaneous corticosterone injection [44].
Consequently, we measured c-Fos expression twenty-four hours after the last corticosterone
injection in order to assess neuronal activity following our chronic corticosterone treatment.
Neuropsin and Stress in Depressive-Like Behaviours
PLOS Genetics | DOI:10.1371/journal.pgen.1006356 October 4, 2016 13 / 22
KO mice featured reduced expression of c-Fos in CA1 and CA3, an area where neuropsin is
highly expressed inWT after chronic corticosterone treatment. This suggests that inactivation
of neuropsin prevents the occurrence of neuronal hyperactivity following chronic corticoste-
rone injection. This may explain why neuropsin KO mice exhibit milder behavioural defects
after chronic corticosterone injection thanWT. By intra-hippocampal injection of viral vectors,
we are able to understand the function of neuropsin more specificallywithin the hippocampus.
In our study, we used a lentiviral vector to knockdown neuropsin on C57BL/6 mice. Addition-
ally we used an AAV9 vector to overexpress neuropsin in the hippocampus of KO mice. Our
data support that the development of depressive-like behaviour following chronic corticoste-
rone injection is mediated by the presence of neuropsin.
Results from gene expression and protein quantification of GR reveal KO mice exhibit a
reduced response to elevated corticosterone. This can also be confirmed by Sgk1 gene expres-
sion. Sgk1 is a direct GR target gene and has been shown to inhibit neurogenesis and be
increased in expression in unmedicated depressed patients [33]. A previous study has also
shown that Sgk1 up-regulates the expression of NMDA receptor subunit GluN2A and GluN2B
[34]. Interestingly, we detected higher levels of gene expression for GluN2B inWT/CORT
mice compared to KO/CORT mice, although no significant difference in protein level was
observedvia western blot. Previous studies have shown GluN2B receptors regulate depressive-
like behaviours and mediate excitotoxic neuronal damage [45, 46]. Moreover, WT/CORTmice
also exhibited higher levels of CamkII, indicating increased levels of intracellular calcium [47].
WT/CORTmice also have lower expression of EAAT1. This may lead to synaptic glutamate
accumulation. Excess glutamate at synapses and an increased influx of calcium ions may trigger
downstream responses that increase ROS production [39]. This hypothesis is supported by our
ROS experiment.WT/CORTmice display higher level of NADPH dependent ROS in the hip-
pocampus compared to KO/CORT mice. It has been suggested that imbalance between the
production of free radicals and the antioxidant capacity of an organism, may contribute to the
neuropathology of neurological and psychiatric diseases, including major depression [48]. In
our study, repeated corticosterone injection increases ROS production capacity in the hippo-
campus. This may contribute to the neuronal and behavioural alterations that we have
observed.Our data suggests neuropsin inactivation protects against corticosterone induced
impairments in hippocampal neuronal architecture and the development of depressive-like
behaviours. The lower ROS production capacity of the KO mice chronically injectedwith corti-
costerone may help explain the protective effects we observewith this model.
In conclusion, we have identified a novel link between the serine protease neuropsin,
chronic stress and depression. We show that neuropsin inactivation has protective effects
against depressive-like behaviours and partially rescues spatial memory after stress. These
effects could be due to an interaction between elevated corticosterone and neuropsin. Overall,
we provide a gene–environment interaction study suggesting that blockade of neuropsin activ-
ity reduces the impairment caused by chronic stress or elevated plasma corticosterone. This
pathway may consequently be a strong candidate for clinical interventions in the treatment of
stress disorders.
Materials and Methods
Animals
Experiments were performed on eight-week-old littermate wild-type and neuropsin knockout
mice [49] with an equal mixed gender balance. Mice were maintained in specific pathogen-free
conditions. They were housed in a 12:12 hour light dark cycle at a temperature of 22°C and a
humidity level of 60–70%. Animals had ad libitum access to food and water. All the protocols
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to proceed in this study were reviewed and approved by the Institutional Animal Care and Use
Committee at Chang Gung University (Permit Number: CGU14-060).
Stress-inducing procedure
The stress procedure combined restraint stress, foot shock, and sleep deprivation. Animals
were subjected to 3 hours restraint stress on the first day. The following day they were placed
in a plexi glass foot shock chamber and given two inescapable 1 mA foot shocks lasting 5 sec-
onds within a period of 3 minutes. The next day, mice were subjected to sleep deprivation by
being placed in a water tank containing multiple and visible platforms (4.5 cm in height and
diameter) surrounded by water for 12 hours [50]. This battery of stress inducing paradigms
was repeated for 28 days.
Behaviour tests
Novelty suppressed feeding: Food pellets were removed from the home cage 24 hours before
testing. Mice were placed for 7 min in a novel cage with food pellets placed in the 4 corners and
a bright light positioned above to illuminate the whole testing chamber. All activity was tracked
by a video tracker. Both the latency to initiate eating and the time spent eating were measured.
Forced swim test: Mice were put into a water tank (diameter = 20 cm), containing 15 cm of
water for 6 min and their immobility time was measured.
Morris water maze: The water maze has four starting positions: north, south, east, and west.
Before beginning the test we chose the order of the starting directions for consistency: north,
east, south and then west. For training, mice were placed in the maze and allowed to swim/
search for the hidden platform for a maximum of 90 seconds. The time taken to reach the plat-
form was recorded. If the mice did not find the platform within 90 seconds they were guided to
the platform. This procedure was repeated three times for each starting direction over three
days (12 trials in total). We then performed the memory test 14 days after training was com-
plete, with the platform removed. We recorded the time each mouse spent in the correct quad-
rant (target zone) where the training platform was previously located.We also recorded how
many times the mice crossed the phantom platform location.
Sucrose preference: For a habituation period of three days, mice were presented with two
drinking bottles; 1% sucrose solution and drinkingwater. The position of the two bottles was
switched every day to reduce side bias. Following habituation, mice were not given water for 6
hours prior to testing.We measured the net weight of both water (W0) and sucrose (S0) before
the test and 24 hours later (W1, S1) when the test was completed. The preference (sucrose con-
sumption %) was calculated by the following formula:
Sucrose consumptionð%Þ ¼ ðS0   S1Þ= ½ðS0   S1Þ þ ðW0   W1Þ  100:
Corticosterone assay
Blood samples were collected to measure basal corticosterone level and the level after 3 hrs of
restraint stress, 30 min after footshock, after 6 hrs of sleep deprivation and 24 hrs after all
stressors via facial vein puncture. Plasma was separated from whole blood by centrifugation
(3000g, 4°C, 10 min) and stored at -80°C until used. Plasma was diluted 1:30 in buffer and mea-
sured using the CorticosteroneEIA kit (Enzo Life Sciences) according to the manufacturer’s
instructions.
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Immunohistochemistry
Brains were harvested and fixed in 4% PFA (pH7.4) for a day. The brains were then dehydrated
for 24 hrs in 25% sucrose solution. All sections for KI67, DCX, c-Fos and CNPase staining
were cut to a thickness of 30 μm on a sliding microtome. Sectionswere mounted on superfrost
slides and dried overnight. Subsequently, slides were incubated in 0.01 mol/L citric buffer for
20 min at 90°C, 3% H2O2 for 10 min, rinsed in PBS, and incubated overnight at room tempera-
ture in rabbit anti-KI67 antibody (1:4000, Vector Lab), goat anti-DCX antibody (1:250, Santa
Cruz), rabbit anti-c-Fos (1:1000, Santa Cruz), or rabbit anti-CNPase (1:1000, Abcam). The
next day, a standard IgG ABC kit (Vector Lab) procedure was used and the slides reacted for
5–10 min with a Sigma DAB tablet. Sections were then counterstained with cresyl violet and
cover-slipped with DPX.
For BrdU staining, following a 3% H2O2 incubation for 10 min, slides were subsequently
incubated in 2MHCL for 30 min at 37°C. Rat anti-BrdU antibody (1:250, Accurate) was
applied overnight. The next day the ABC kit procedure was followed and the slides were
reacted with a Sigma DAB tablet. Hippocampus cells were counted bilaterally on every eighth
section through the entire rostrocaudal extent of the granule cell layer.
Quantification
All slides were randomized and coded before quantitative analysis. Slides (half brain) were
examined under a 20× objective. DCX, KI67 and BrdU labelled cells were counted on every
eighth section through the entire rostrocaudal extent of the granule cell layer (6 sections per
animal). The number of cells counted was then multiplied by sixteen to obtain an estimate of
the total number of DCX, KI67 and BrdU positive cell in the dentate gyrus. For c-Fos labelled
cells, we counted cells on every eighth section through the entire rostrocaudal extent of the
dentate gyrus, CA1 and CA3 areas (6 sections per animal). The raw data was then modified as
detailed above.
Golgi staining
Brains were harvested and stained using the superGolgi Kit (Bioenno Tech) in accordance with
the manufacturer's instructions. Brains were impregnated with solution for 9 days. This was
followed by 2 days of dehydration in sucrose. Brains were subsequently sectioned coronally at a
thickness of 150 μm using a microtome. We calculated the spine density of the secondary
branches of pyramidal neuron apical dendrites in CA3.We selected a total of 18 neurons per
each animal. Three different neurons were randomly selected for measuring per brain slice in
bothWT and KO mice (n = 4). A total of six brain slices were analysed per animal.
Viral vector preparation and intra-hippocampal injections
For the neuropsin overexpression experiment and control, DNA fragments that encodedKLK8
or EGFP were created by PCR and subcloned into the NotI site of a AAV9 virus construct.
Recombinant AAV9 vectors were produced by a standard triple-plasmid transfectionmethod
and purified by two rounds of CsCl centrifugation. The physical vector titres of AAVs were
quantified by measuring the number of packaged vector genomes using a real-time PCR
method. For the neuropsin knockdown experiment and control, a klk8 short hairpin RNA
(shRNA) lentiviral vector and scrambled sequence control vector were obtained from the
National RNAi core facility (Institute of Molecular Biology, Academia Sinica, Taiwan). The tar-
get sequence for Klk8 shRNA was: CCTCAACTGTGCGGAAGTGAA.
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For the viral vector injections, surgery was performed under anaesthesia (a Zoletil-Rompun
mixture). Mice received bilateral injections of viral vectors into hippocampus in a volume of
1.5 μl (5x1013 VG/ml for AAV9 viral vector, 5.6x106 RIU/ml for lentiviral vector) under stereo-
taxic guidance. There were four injection sites in total (For dorsal hippocampus, AP– 2.2mm,
ML ± 2.0 mm from bregma and DV—1.8 mm from dura; for ventral hippocampus, AP—
3.0mm,ML ± 3.0 and DV—3.3 mm). (S4A Fig)
mRNA quantification
Hippocampal tissue was collected fromWT and KO mice. mRNA was extracted using a
RNeasy Lipid Tissue Kit (Qiagen). cDNA was then made using SuperScript III reverse tran-
scriptase (Invitrogen). Experiments were performed in duplicate. Gene expression levels were
then calculated by the ΔΔCt method and normalized against a Gapdh control. Primers used in
this study are in the Table 1.
Western blot analysis
Protein extracts were obtained by lysing tissue in 1% SDS. Samples were homogenized and
heated at 100°C for 10 min. Proteins were then separated by sodium dodecyl sulphate–poly-
acrylamide gel electrophoresis and electro-transferred onto nitrocellulosemembranes. Blots
were incubated with primary antibody (GR 1:1000, Santa Cruz; SGK1 1:1000, BOSTER; Fkbp5
1:3000, Santa Cruz; NR2b 1:1000, Millipore; CamKII 1:1000, Santa Cruz; EAATI 1:1000, Alpha
Diagnostic) placed in TBST and 5% non-fat milk overnight at 4°C. Subsequently, blots were
washed and probed with the respective horseradish peroxidase secondary antibody for 1 h at
room temperature. The immunoreactive bands were visualized using ECL detection reagent
(GE Healthcare, RPN2106). Assessment of the band intensities were performed using the Che-
miDocMP from Bio-Rad.
Superoxide anion analysis
Superoxide anion production in the hippocampus tissues was measured by modified lucigenin-
enhanced chemiluminescence.This method to test superoxide anion production level in tissue
is based on the nitro blue tetrazolium (NBT) reductionmethod [51]. Hippocampi were iso-
lated, chopped and then placed in a white plate containing Krebs buffer. Lucigenin (25 μM)
Table 1. Primers used for quantification of mRNA expression.
Forward Reverse
NP (Klk8) CGTGGATCCTTCTGCTTCTG CCCCCACAGATCAGTCTCTC
GR (Nr3c1) ACGCCGACTTGTTTATCTGG GAAAAGGACGCCAGACTCC
Sgk1 CTGCTCGAAGCACCCTTACC TCCTGAGGATGGGACATTTTCA
Fkbp5 AGCACACATCCCGTGTTCTA TGCTGGGTTCTCTCCATTGT
GluN2A ACGTGACAGAACGCGAACTT TCAGTGCGGTTCATCAATAACG
GluN2B GCCATGAACGAGACTGACCC GCTTCCTGGTCCGTGTCATC
VGluT1 GGTGGAGGGGGTCACATAC AGATCCCGAAGCTGCCATAGA
EAAT1 ACCAAAAGCAACGGAGAAGAG GGCATTCCGAAACAGGTAACTC
CamK2a TGCCTGGTGTTGCTAACCC CCATTAACTGAACGCTGGAACT
CamK2b GCACGTCATTGGCGAGGAT ACGGGTCTCTTCGGACTGG
Cnp ACCATTGTCCCCCTATACCC TATGTATGGGCAAAGCCACA
Mog AGCTGCTTCCTCTCCCTTCTC ACTAAAGCCCGGATGGGATAC
Gapdh TGACGTGCCGCCTGGAGAAAC CCGGCATCGAAGGTGGAAGAG
doi:10.1371/journal.pgen.1006356.t001
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was added to test the basal level of superoxide anion production. NADPH (500 μM) was then
added to stimulate NADPH-oxidase dependent ROS production. The magnitude of superoxide
anion production was normalized for the dry weight of the chopped hippocampus.
Statistical analysis
The mean ± SEM was determined for each group. Statistical analyses were performed using
Graphpad Prism software. Data were analyzed via an analysis of variance (ANOVA) or t-test
as appropriate. Fisher's LSD method was performedwhen applicable. Differences were consid-
ered significant when p was less than 0.05.
Supporting Information
S1 Fig. No significant difference in open field activity betweenWT and neuropsin KO
mice. (A) No significant basal activity difference betweenWT and KO mice. However, chronic
stress significantly decreased open field activity (B) No significant difference in activity
betweenWT and KO following oil injection, however, corticosterone injection greatly
decreased activity in the open field. Values represent mean ± SEM.  p< 0.05.
(TIFF)
S2 Fig. Neuropsin deficientmice exhibit no significant difference in plasma corticosterone
level compared to WTmice before, during and after stress. Plasma corticosterone onWT
and KO mice (n = 8) before stress, after 3hrs of restraint stress, 30 min after footshock, after 6
hrs of sleep deprivation and 24 hrs after all stressors had ceased. Stress strongly elevated plasma
corticosterone level but there was no significant effect of neuropsin on these levels. Values rep-
resent mean ± SEM.
(TIF)
S3 Fig. Viral vectorsmediated expression of neuropsin in the hippocampuswith chronic
corticosterone treatment alters depressive-likebehaviour and spatial memory. Fourteen
days after intrahippocampal viral vector injections, all the mice were given daily corticosterone
injections. Two weeks later, all mice were subjected to behaviour tests. (A) Hippocampal over-
expression of neuropsin in KO mice (NP/OE, n = 8) increases depressive-like behaviour as
measured by the novelty suppressed feeding test and forced swim test, although there is no sig-
nificant difference in the sucrose preference test compared to neuropsin KO mice (NP/KO,
n = 8) (B) No significant difference in the water maze learning curves betweenNP/OE and NP/
KO mice. Two weeks after water maze experiment, NP/OEmice exhibited fewer phantom plat-
form crosses in a memory test. (C) Knockdown hippocampal neuropsin (n = 9) attenuated the
development of depressive-like behaviour in novelty suppressed feeding and forced swim tests
compared to control mice (n = 9). (D) No significant difference in the water maze learning
curves between control and knockdownmice was observed, however, there was a significant
difference in the number of phantom platform crosses during the memory test. Values repre-
sent mean ± SEM.  p< 0.05,  p< 0.01,  p< 0.001.
(TIF)
S4 Fig. Viral vectorsmediate the expression of hippocampalneurogenesis. (A) The injected
dye shows the positioning of the intrahippocampal injection. (B) KO mice injected with neu-
ropsin overexpression viral vector (NP/OE) in the hippocampus feature significantly increased
hippocampal neuropsin mRNA compared toWT (NP/WT) and KO (NP/KO) mice (n = 5 in
each group). (B((Mice injectedwith neuropsin shRNA lentiviral vector feature significantly
decreased neuropsin expression in the hippocampus (n = 6 in each group). Values represent
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mean ± SEM.  p< 0.05,  p< 0.001.
(TIFF)
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